IHM
FOLD

Iguana Healthcare Management’s Amicus Therapeutics FOLD Stock Holding History

Iguana Healthcare Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-60,000
Closed -$905K – 67
2017
Q3 		$905K Buy
+60,000
New +$794K 0.49% 55
2014
Q1 		– Sell
-265,000
Closed -$623K – 86
2013
Q4 		$623K Buy
+265,000
New +$582K 0.36% 64

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Iguana Healthcare Management's FOLD Position: Q4 2017 in Review

Iguana Healthcare Management sold out of Amicus Therapeutics (FOLD) in Q4 2017, closing a stake of 60,000 shares — an estimated $905K sold.

Iguana Healthcare Management first reported a position in FOLD in Q4 2013 and held it in 2 quarters. The position peaked at $905K in Q3 2017. 185 funds tracked by Wall St. Rank hold FOLD as of Q4 2017.

  • Iguana Healthcare Management reported no remaining Amicus Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Iguana Healthcare Management sold 60,000 Amicus Therapeutics shares in Q4 2017, an estimated $905K.
  • Iguana Healthcare Management first reported a position in Amicus Therapeutics in Q4 2013 and held it in 2 quarters.
  • Iguana Healthcare Management's Amicus Therapeutics position peaked at $905K in Q3 2017.
  • 185 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2017.

Based on Iguana Healthcare Management's 13F filing for Q4 2017, filed 14 Feb 2018.